A combination of total tau and neurofilaments discriminates between neurodegenerative and primary psychiatric disorders
- 1 July 2020
- journal article
- research article
- Published by Wiley in European Journal of Neurology
- Vol. 27 (7), 1164-1169
- https://doi.org/10.1111/ene.14247
Abstract
Background and purpose Neuropsychiatric symptoms are commonly observed in neurodegenerative diseases. No biomarker is currently available to diagnose psychiatric conditions. As a consequence, the distinction between psychiatric and neurodegenerative disorders can be challenging in daily practice. Methods This retrospective study included a cohort of 64 primary psychiatric patients (PSY) and 162 patients suffering from various neurodegenerative disorders (NDG). Total tau (t-Tau), phosphorylated tau (p-Tau), A beta 1-42 peptide (A beta 1-42) and neurofilament light chain protein (NfL) were analysed in cerebrospinal fluid. The discrimination between PSY and NDG patients was assessed using both individual and combined analysis of cerebrospinal fluid markers. Results Cerebrospinal fluid t-Tau and NfL exhibited the best diagnostic performances: they were able to discriminate between PSY and each subgroup of NDG patients. t-Tau had the highest sensitivity (93.8%) but a poor specificity (67.3%). Indeed, some NDG subgroups exhibited low t-Tau levels comparable to PSY patients. A sequential combination t-Tau + NfL improved the characterization of patients, especially in these particular subgroups, increasing specificity up to 89.6% without modification of sensitivity. Finally, this combination of markers led to a high classification rate of 90.7% for the whole cohort of patients. Conclusion The sequential combination t-Tau + NfL enables the biological detection of neurodegeneration in patients with psychiatric features. This association of markers seems to be a promising strategy for a differential diagnosis in clinical practice between primary psychiatric conditions and neurodegenerative disorders, thus improving medical care of patients.This publication has 27 references indexed in Scilit:
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's diseaseAlzheimer's & Dementia, 2018
- Antibody-Mediated EncephalitisThe New England Journal of Medicine, 2018
- CSF biomarkers for the differential diagnosis of Alzheimer's disease: A large‐scale international multicenter studyAlzheimer's & Dementia, 2015
- Principles and management of neuropsychiatric symptoms in Alzheimer’s dementiaAlzheimer's Research & Therapy, 2015
- Depressive symptoms in neurodegenerative diseasesWorld Journal of Clinical Cases, 2015
- Psychotic symptoms in frontotemporal dementia: a diagnostic dilemma?International Psychogeriatrics, 2014
- Management of frontotemporal dementia in mental health and multidisciplinary settings.International Review of Psychiatry, 2013
- The Diagnostic Challenge of Psychiatric Symptoms in Neurodegenerative DiseaseBritish Journal of Psychology, 2011
- The global burden of mental disorders: An update from the WHO World Mental Health (WMH) SurveysEpidemiologia e Psichiatria Sociale, 2009
- Presentation and Management of Psychosis in Parkinson’s Disease and Dementia With Lewy BodiesAmerican Journal of Psychiatry, 2007